{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:53:38Z","timestamp":1791201218271,"version":"4.2.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbi.2014.11.004","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T08:11:25Z","timestamp":1416211885000},"page":"44-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development"],"prefix":"10.1016","volume":"47","author":[{"given":"Louis","family":"Jacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Leib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna M.","family":"Ollila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lodie","family":"Bonvalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2014.11.004_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.033","article-title":"Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants","volume":"50C","author":"Ahmed","year":"2014","journal-title":"J. Autoimmun."},{"issue":"8","key":"10.1016\/j.bbi.2014.11.004_b0010","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","author":"Aran","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2014.11.004_b0015","unstructured":"Assessment Report for Arepanrix-European Medicines Agency, 2010. <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/001201\/WC500089740.pdf>."},{"key":"10.1016\/j.bbi.2014.11.004_b0020","unstructured":"Assessment Report for Focetria, European Medicines Agency, 2009. <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Public_assessment_report\/human\/000710\/WC500023755.pdf>."},{"issue":"35","key":"10.1016\/j.bbi.2014.11.004_b0025","doi-asserted-by":"crossref","first-page":"E3735","DOI":"10.1073\/pnas.1412189111","article-title":"Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns","volume":"111","author":"Bergman","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"33","key":"10.1016\/j.bbi.2014.11.004_b0030","doi-asserted-by":"crossref","first-page":"20313","DOI":"10.1074\/jbc.272.33.20313","article-title":"Protein oxidation in aging, disease, and oxidative stress","volume":"272","author":"Berlett","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbi.2014.11.004_b0035","first-page":"220","article-title":"Narcolepsy, clinical features and aetiology","volume":"17","author":"Billiard","year":"1985","journal-title":"Ann. Clin. Res."},{"issue":"3\u20134","key":"10.1016\/j.bbi.2014.11.004_b0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF01309926","article-title":"Studies on the development of the charge heterogeneity of the influenza virus glycoproteins","volume":"83","author":"Bosch","year":"1985","journal-title":"Arch. Virol."},{"issue":"33","key":"10.1016\/j.bbi.2014.11.004_b0045","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2013.05.007","article-title":"The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect","volume":"31","author":"Calabro","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bbi.2014.11.004_b0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01591484","article-title":"Comparative analysis of six European influenza vaccines","volume":"15","author":"Chaloupka","year":"1996","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"11","key":"10.1016\/j.bbi.2014.11.004_b0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/glycob\/8.11.1045","article-title":"Quantitative analysis of sugar constituents of glycoproteins by capillary electrophoresis","volume":"8","author":"Chen","year":"1998","journal-title":"Glycobiology"},{"issue":"12","key":"10.1016\/j.bbi.2014.11.004_b0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.sleep.2013.06.017","article-title":"Association analysis of the major histocompatibility complex, Class II, DQ \u03b21 gene, HLA-DQB1, with narcolepsy in Han Chinese patients from Taiwan","volume":"14","author":"Chen","year":"2013","journal-title":"Sleep Med."},{"issue":"6","key":"10.1016\/j.bbi.2014.11.004_b0065","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1399-3011.1987.tb03390.x","article-title":"Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins","volume":"30","author":"Clarke","year":"1987","journal-title":"Int. J. Pept. Protein Res."},{"issue":"11","key":"10.1016\/j.bbi.2014.11.004_b0070","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1212\/WNL.62.11.2137","article-title":"A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"issue":"Pt 8","key":"10.1016\/j.bbi.2014.11.004_b0330","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/brain\/awt187","article-title":"Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France","volume":"136","author":"Dauvilliers","year":"2013","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.bbi.2014.11.004_b0080","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/sleep\/33.11.1428","article-title":"Post-H1N1 narcolepsy-cataplexy","volume":"33","author":"Dauvilliers","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.bbi.2014.11.004_b0085","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/148178","article-title":"Similarities and differences in the glycosylation mechanisms in prokaryotes and eukaryotes","volume":"2010","author":"Dell","year":"2010","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.bbi.2014.11.004_b0335","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000000987","article-title":"Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States","author":"Duffy","year":"2014","journal-title":"Neurology"},{"issue":"46\u201347","key":"10.1016\/j.bbi.2014.11.004_b0095","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza a subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.bbi.2014.11.004_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003270","article-title":"ImmunoChip study implicates antigen presentation to T cells in narcolepsy","volume":"9","author":"Faraco","year":"2013","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.bbi.2014.11.004_b0105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0021-9258(19)75855-4","article-title":"Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. succinimide-linked reactions that contribute to protein degradation","volume":"262","author":"Geiger","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbi.2014.11.004_b0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the TCR alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.bbi.2014.11.004_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003880","article-title":"Genome wide analysis of narcolepsy in china implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic","volume":"9","author":"Han","year":"2013","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.bbi.2014.11.004_b0120","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.23799","article-title":"Decreased incidence of childhood narcolepsy 2years after the 2009 H1N1 winter flu pandemic","volume":"73","author":"Han","year":"2013","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.bbi.2014.11.004_b0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.bbi.2014.11.004_b0130","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","article-title":"Incidence of narcolepsy in norwegian children and adolescents after vaccination against H1N1 influenza A","volume":"14","author":"Heier","year":"2013","journal-title":"Sleep Med."},{"key":"10.1016\/j.bbi.2014.11.004_b0135","unstructured":"Highlights of Prescription Informations for Flulaval (GSK), 2014. <https:\/\/www.gsksource.com\/gskprm\/htdocs\/documents\/FLULAVAL.PDF>."},{"key":"10.1016\/j.bbi.2014.11.004_b0340","article-title":"Census of narcolepsy cataplexy and sleep life among teenagers in Fujisawa city","author":"Honda","year":"1979","journal-title":"Sleep Res"},{"key":"10.1016\/j.bbi.2014.11.004_b0145","unstructured":"ICSD3, 2014. American Academy of Sleep Medicine."},{"issue":"6","key":"10.1016\/j.bbi.2014.11.004_b0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/sleep\/10.6.608","article-title":"Narcolepsy is a rare disease in Israel","volume":"10","author":"Lavie","year":"1987","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.bbi.2014.11.004_b0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.bbi.2014.11.004_b0160","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/sleep\/32.12.1548","article-title":"Narcolepsy and streptococcal infections","volume":"32","author":"Longstreth","year":"2009","journal-title":"Sleep"},{"issue":"187","key":"10.1016\/j.bbi.2014.11.004_b0345","doi-asserted-by":"crossref","first-page":"187ra70","DOI":"10.1126\/scitranslmed.3005996","article-title":"Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses","volume":"5","author":"Medina","year":"2013","journal-title":"Sci. Trans. Med."},{"issue":"8","key":"10.1016\/j.bbi.2014.11.004_b0170","doi-asserted-by":"crossref","first-page":"e68402","DOI":"10.1371\/journal.pone.0068402","article-title":"No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland","volume":"8","author":"Mel\u00e9n","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbi.2014.11.004_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6061\/clinics\/2012(01)12","article-title":"Narcolepsy after A\/H1N1 vaccination","volume":"67","author":"Mendes","year":"2012","journal-title":"Clinics"},{"issue":"2 Suppl. 1","key":"10.1016\/j.bbi.2014.11.004_b0180","first-page":"S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.bbi.2014.11.004_b0185","first-page":"1012","article-title":"HLA DQB1\u22170602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot","year":"1997","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.bbi.2014.11.004_b0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1399-0039.1997.tb02761.x","article-title":"Extensive HLA Class II studies in 58 non-DRB1\u221715 (DR2) narcoleptic patients with cataplexy","volume":"49","author":"Mignot","year":"1997","journal-title":"Tissue Antigens"},{"issue":"3","key":"10.1016\/j.bbi.2014.11.004_b0195","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/318799","article-title":"Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups","volume":"68","author":"Mignot","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbi.2014.11.004_b0200","first-page":"f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted Pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"9","key":"10.1016\/j.bbi.2014.11.004_b0205","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2014.11.004_b0215","unstructured":"Narcolepsy in Association with Pandemic Influenza Vaccines, 2012. European center for disease prevention and control. <http:\/\/www.ecdc.europa.eu\/en\/publications\/publications\/vaesco%20report%20final%20with%20cover.pdf>."},{"issue":"4","key":"10.1016\/j.bbi.2014.11.004_b0220","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.vaccine.2011.11.081","article-title":"An additional oligosaccharide moiety in the HA of a Pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs","volume":"30","author":"Nicolson","year":"2012","journal-title":"Vaccine"},{"issue":"9197","key":"10.1016\/j.bbi.2014.11.004_b0225","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bbi.2014.11.004_b0230","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.bbi.2014.11.004_b0235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2807\/1560-7917.ES2014.19.17.20789","article-title":"Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010","volume":"19","author":"O\u2019Flanagan","year":"2014","journal-title":"Euro. Surveill."},{"issue":"3","key":"10.1016\/j.bbi.2014.11.004_b0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbi.2014.11.004_b0245","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/joim.12150","article-title":"Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2years of follow-up","volume":"275","author":"Persson","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbi.2014.11.004_b0250","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bbi.2014.11.004_b0255","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1073\/pnas.75.8.3625","article-title":"Influenza virus proteins: identity, synthesis, and modification analyzed by two-dimensional gel electrophoresis","volume":"75","author":"Privalsky","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbi.2014.11.004_b0260","unstructured":"R Core Team, 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL <http:\/\/www.R-Project.org\/>. 2014."},{"issue":"9","key":"10.1016\/j.bbi.2014.11.004_b0265","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.vaccine.2010.12.044","article-title":"The development of vaccine viruses against pandemic A(H1N1) influenza","volume":"29","author":"Robertson","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.bbi.2014.11.004_b0270","doi-asserted-by":"crossref","first-page":"e92153","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012\u201313 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbi.2014.11.004_b0275","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/S0021-9258(18)83327-0","article-title":"Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins","volume":"264","author":"Stephenson","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2014.11.004_b0280","unstructured":"Summary of Product Characteristics-H5N1, 2014. <http:\/\/ec.europa.eu\/health\/documents\/community-register\/2011\/20110418101870\/anx_101870_en.pdf>."},{"key":"10.1016\/j.bbi.2014.11.004_b0285","unstructured":"Summary of Product Characteristics-Pandemrix, 2010. <http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000832\/WC500038121.pdf>."},{"key":"10.1016\/j.bbi.2014.11.004_b0355","article-title":"An epidemiological study on prevalence of narcolepsy in Japanese","author":"Tashiro","year":"1992","journal-title":"Sleep Res"},{"issue":"2","key":"10.1016\/j.bbi.2014.11.004_b0295","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.virol.2010.08.027","article-title":"A mutation in the receptor binding site enhances infectivity of 2009 H1N1 influenza hemagglutinin pseudotypes without changing antigenicity","volume":"407","author":"Wang","year":"2010","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.bbi.2014.11.004_b0300","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.vaccine.2012.12.015","article-title":"The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns","volume":"31","author":"Wijnans","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bbi.2014.11.004_b0305","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.12522","article-title":"Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine in England","author":"Winstone","year":"2014","journal-title":"Dev. Med. Child Neurol"},{"issue":"2 Suppl. 1","key":"10.1016\/j.bbi.2014.11.004_b0310","first-page":"S37","article-title":"Childhood narcolepsy","volume":"50","author":"Wise","year":"1998","journal-title":"Neurology"},{"issue":"7122","key":"10.1016\/j.bbi.2014.11.004_b0315","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/nature05379","article-title":"The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA","volume":"444","author":"Ye","year":"2006","journal-title":"Nature"},{"issue":"Pt 6","key":"10.1016\/j.bbi.2014.11.004_b0360","first-page":"1127","article-title":"Nucleoproteins of animal influenza viruses","volume":"65","author":"Zhirnov","year":"1984","journal-title":"Nucleoproteins of animal influenza viruses, in contrast to those of human strains, are not cleaved in infected cells"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114005194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159114005194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:41:00Z","timestamp":1760168460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159114005194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":63,"alternative-id":["S0889159114005194"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2014.11.004","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2014.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}